Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Retraction: Transactivation of the EGR1 Gene Contributes to Mutant p53 Gain of Function.

Weisz L, Zalcenstein A, Stambolsky P, Cohen Y, Goldfinger N, Oren M, Rotter V.

Cancer Res. 2019 Apr 15;79(8):2085. doi: 10.1158/0008-5472.CAN-19-0560. No abstract available.

PMID:
30987981
2.

Modulation of the vitamin D3 response by cancer-associated mutant p53.

Stambolsky P, Tabach Y, Fontemaggi G, Weisz L, Maor-Aloni R, Siegfried Z, Shiff I, Kogan I, Shay M, Kalo E, Blandino G, Simon I, Oren M, Rotter V.

Cancer Cell. 2010 Mar 16;17(3):273-85. doi: 10.1016/j.ccr.2009.11.025. Erratum in: Cancer Cell. 2010 May 18;17(5):523. Sigfried, Zahava [corrected to Siegfried, Zehava].

3.

A cell chip for sequential imaging of individual non-adherent live cells reveals transients and oscillations.

Schiffenbauer YS, Kalma Y, Trubniykov E, Gal-Garber O, Weisz L, Halamish A, Sister M, Berke G.

Lab Chip. 2009 Oct 21;9(20):2965-72. doi: 10.1039/b904778f. Epub 2009 Jul 15.

PMID:
19789751
4.

Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II.

Kalo E, Buganim Y, Shapira KE, Besserglick H, Goldfinger N, Weisz L, Stambolsky P, Henis YI, Rotter V.

Mol Cell Biol. 2007 Dec;27(23):8228-42. Epub 2007 Sep 17.

5.

Transcription regulation by mutant p53.

Weisz L, Oren M, Rotter V.

Oncogene. 2007 Apr 2;26(15):2202-11. Review.

PMID:
17401429
6.

Mutant p53 enhances nuclear factor kappaB activation by tumor necrosis factor alpha in cancer cells.

Weisz L, Damalas A, Liontos M, Karakaidos P, Fontemaggi G, Maor-Aloni R, Kalis M, Levrero M, Strano S, Gorgoulis VG, Rotter V, Blandino G, Oren M.

Cancer Res. 2007 Mar 15;67(6):2396-401. Erratum in: Cancer Res. 2015 Sep 3;:null.

7.

Inactivation of myocardin and p16 during malignant transformation contributes to a differentiation defect.

Milyavsky M, Shats I, Cholostoy A, Brosh R, Buganim Y, Weisz L, Kogan I, Cohen M, Shatz M, Madar S, Kalo E, Goldfinger N, Yuan J, Ron S, MacKenzie K, Eden A, Rotter V.

Cancer Cell. 2007 Feb;11(2):133-46.

8.

Regulation of AIF expression by p53.

Stambolsky P, Weisz L, Shats I, Klein Y, Goldfinger N, Oren M, Rotter V.

Cell Death Differ. 2006 Dec;13(12):2140-9. Epub 2006 May 26.

9.

Repression of the MSP/MST-1 gene contributes to the antiapoptotic gain of function of mutant p53.

Zalcenstein A, Weisz L, Stambolsky P, Bar J, Rotter V, Oren M.

Oncogene. 2006 Jan 19;25(3):359-69.

PMID:
16170349
10.

Transactivation of the EGR1 gene contributes to mutant p53 gain of function.

Weisz L, Zalcenstein A, Stambolsky P, Cohen Y, Goldfinger N, Oren M, Rotter V.

Cancer Res. 2004 Nov 15;64(22):8318-27. Retraction in: Cancer Res. 2019 Apr 15;79(8):2085.

11.

Mutant p53 gain of function: repression of CD95(Fas/APO-1) gene expression by tumor-associated p53 mutants.

Zalcenstein A, Stambolsky P, Weisz L, Müller M, Wallach D, Goncharov TM, Krammer PH, Rotter V, Oren M.

Oncogene. 2003 Aug 28;22(36):5667-76.

PMID:
12944915
12.

Integrity of the N-terminal transcription domain of p53 is required for mutant p53 interference with drug-induced apoptosis.

Matas D, Sigal A, Stambolsky P, Milyavsky M, Weisz L, Schwartz D, Goldfinger N, Rotter V.

EMBO J. 2001 Aug 1;20(15):4163-72.

13.

[Treatment of superficial lesions of the eye with sodium cromoglycate].

Verin P, Vildy A, Weisz L, Thiempont P, Tessier P.

Bull Soc Ophtalmol Fr. 1984 Oct;84(10):1063-4. French. No abstract available.

PMID:
6443346
14.

[Papilledema following cataract operation in children].

Vérin P, Weisz L, Comte P.

Bull Soc Ophtalmol Fr. 1984 Aug-Sep;84(8-9):941-4. French. No abstract available.

PMID:
6535666
15.

[Genetic aspects of peripheral alterations in a family with retinal detachment].

Constantinides G, François P, Weisz L, Puech BB.

Bull Soc Ophtalmol Fr. 1979 Nov-Dec;79(11-12):1091-2. French. No abstract available.

PMID:
552950
16.

[Study of the incidence and etiopathogenesis of hypertension in young adults].

DOBO S, MOGA A, OBRASCU C, POP V, SUCIU I, VLAICU R, WEISZ L.

Bul Stiint Sect Stiint Medicale Acad Republicii Pop Romane. 1956 Apr-Jun;8(2):371-84. Romanian. No abstract available.

PMID:
13396333

Supplemental Content

Support Center